1. Home
  2. FORTY vs OCUL Comparison

FORTY vs OCUL Comparison

Compare FORTY & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Formula Systems (1985) Ltd.

FORTY

Formula Systems (1985) Ltd.

HOLD

Current Price

$117.08

Market Cap

1.8B

Sector

Technology

ML Signal

HOLD

Logo Ocular Therapeutix Inc.

OCUL

Ocular Therapeutix Inc.

BUY

Current Price

$6.65

Market Cap

1.5B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
FORTY
OCUL
Founded
1985
2006
Country
Israel
United States
Employees
N/A
325
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
1998
2014

Fundamental Metrics

Financial Performance
Metric
FORTY
OCUL
Price
$117.08
$6.65
Analyst Decision
Strong Buy
Analyst Count
0
12
Target Price
N/A
★ $26.00
AVG Volume (30 Days)
2.3K
★ 3.7M
Earning Date
11-19-2026
11-03-2026
Dividend Yield
★ 9.68%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $1,990,000.00
Revenue This Year
N/A
$1.71
Revenue Next Year
N/A
$93.12
P/E Ratio
$36.65
★ N/A
Revenue Growth
N/A
★ 3.48
52 Week Low
$102.01
$6.00
52 Week High
$190.56
$16.44

Technical Indicators

Market Signals
Indicator
FORTY
OCUL
Relative Strength Index (RSI) 48.19 26.48
Support Level $109.16 $6.23
Resistance Level $119.68 $9.93
Average True Range (ATR) 1.52 0.42
MACD -0.67 -0.05
Stochastic Oscillator 28.17 15.36

Price Performance

Historical Comparison
FORTY
OCUL

About FORTY Formula Systems (1985) Ltd.

Formula Systems (1985) Ltd is an information technology company that is principally engaged through its directly and indirectly held investees in providing software consulting services, selling and marketing computer-based business solutions and hardware products from a wide range of domestic and international manufacturers, as well as developing proprietary software solutions. It delivers solutions in Israel and in numerous countries to customers with complex IT services needs. It designs and implements IT solutions and software systems that improve the productivity of customers' existing IT assets, enable them to effectively manage their operations and reduce their business risks in the face of changing business environments.

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

Share on Social Networks: